Aelis Farma is “embedded” in the Neurocenter Magendie, where the company benefits from the expertise of its researchers thanks to a specific collaborative contract. The scientific discovery behind Aelis Farma’s innovation results from a close collaboration between these world class specialists in various fields of neurobiology. The following Inserm researchers are all members of the company’s scientific committee, shareholders, and contribute actively to its current research and developments.
Daniela Cota, MD
is a neuroscientist with a clinical endocrinology background. She has large experience in the study of the pathophysiological role of the CB1 receptors both in animals and humans and in CB1 pharmacology.
Monique Vallée, PhD
is a neuroscientist with a broad background in steroid physiology and psychopharmacology. She has a great experience in analytical and behavioral methods and in the study of the pathophysiology of cannabis abuse.
Giovanni Marsicano, VD, PhD
is one of the most renowned experts in the field of physiological and pathophysiological roles of the CB1 receptors using genetic approaches.
Jean Michel Revest, PhD
is a neuroscientist with a broad background in the molecular mechanisms of signal transduction in the central nervous system and in particular in understanding the molecular basis of drug addiction and stress-related pathologies.